Prolonged Infusion of Dexmedetomidine in Critically-ill Children

Cinara Andreolio1, Jefferson Pedro Piva, Elisa Baldasso

  • 1Pediatric Intensive Care Unit at Hospital de Clinicas de Porto Alegre and Pediatric Emergency and Intensive Care Department Medical School UFRGS University, Brazil. Correspondence to: Cinara Andreolio Rua Ramiro Barcelos, 2350 Zip Code 90035003. cinarandreolio@hotmail.com.

Indian Pediatrics
|November 28, 2016
PubMed

Insights

Dexmedetomidine is a safe sedative for critically ill children, showing few side effects during mechanical ventilation weaning and post-surgery care. This study highlights its use in pediatric intensive care units.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pharmacology
  • Sedation Management

Background:

  • Dexmedetomidine is increasingly used for sedation in pediatric intensive care units (PICUs).
  • Understanding its indications, dosing, and side effect profile is crucial for safe administration.

Purpose of the Study:

  • To describe the main indications, doses, infusion duration, and side effects of dexmedetomidine.
  • To evaluate the safety and efficacy of dexmedetomidine in critically ill children.

Main Methods:

  • Observational and retrospective study design.
  • Evaluation of dexmedetomidine use in a pediatric intensive care unit.
  • Analysis of data from 77 children receiving dexmedetomidine infusions.

Main Results:

  • Dexmedetomidine was used for mechanical ventilation weaning (32.5%), post-neurosurgery/airway surgery (24.7%), non-invasive ventilation (13%), and refractory tachycardia (6.5%).
  • A significant decrease in mean arterial pressure and heart rate was observed after 6 hours of infusion.
  • Eight percent of children experienced side effects (hypotension, bradycardia, somnolence), leading to drug withdrawal.

Conclusions:

  • Dexmedetomidine can be safely used as a sedative in critically ill children.
  • The drug demonstrates a favorable side effect profile when used appropriately in the pediatric intensive care setting.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
660
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
346
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
851
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
306
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
323
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
116